Manned Spaceflight And Basic Research: Their Fortunes Rise And Fall Together

An ongoing debate within the United States science community pits those who favor government funding of manned spaceflight against those who believe that such funding is appropriated at the expense of smaller scientific research projects. The argument is treated on both sides as a zero-sum game, in which an absolute choice must be made between supporting, on one hand, a lot of small science programs and, on the other hand, a few large, manned space programs. Those who would protect disciplines

Written byHarvey Willenberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An ongoing debate within the United States science community pits those who favor government funding of manned spaceflight against those who believe that such funding is appropriated at the expense of smaller scientific research projects. The argument is treated on both sides as a zero-sum game, in which an absolute choice must be made between supporting, on one hand, a lot of small science programs and, on the other hand, a few large, manned space programs. Those who would protect disciplines that do not require human presence in space claim that manned spaceflight drains the budget for "real" science. However, an honest analysis of historical fact indicates that this has never been the case. Indeed, if you look at how the government has spent taxpayers' money for the past 30 years, you'll see that the fortunes of science in general and of spaceflight rise and fall together.

The federal budget ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies